REGENERON PHARMACEUTICALS INC
REGENERON PHARMACEUTICALS INC
Action · US75886F1075 · REGN · 881535 (XNAS)
Aperçu Indicateurs financiers
494,00 USD
2,26 % 10,93 USD
NASDAQ (XNAS) · Cours et graphiques actuels sur MoneyPeak
06.06.2025 20:42

Cours actuels de REGENERON PHARMACEUTICALS INC

BourseTickerDeviseDernier échangeCoursVariation journalière
XNAS: NASDAQ
NASDAQ
REGN
USD
06.06.2025 20:42
494,00 USD
483,07 USD
+2,26 %
XLON: London
London
0R2M.L
USD
06.06.2025 15:13
496,04 USD
483,07 USD
+2,68 %

Performance

Jour Semaine Mois 3 mois 6 mois 1 an 5 ans
0,00 % 0,55 % -11,55 % -29,27 % -36,39 % -50,84 % -17,25 %

Profil de l'entreprise pour REGENERON PHARMACEUTICALS INC Action

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macular edema following retinal vein occlusion, including macular edema following central retinal vein occlusion and macular edema following branch retinal vein occlusion. It also provides Dupixent injection to treat atopic dermatitis and asthma in adults and pediatrics; Libtayo injection to treat metastatic or locally advanced cutaneous squamous cell carcinoma;Praluent injection for heterozygous familial hypercholesterolemia or clinical atherosclerotic cardiovascular disease in adults; REGEN-COV for covid-19; and Kevzara solution for treating rheumatoid arthritis in adults. In addition, the company offers Inmazeb injection for infection caused by Zaire ebolavirus; ARCALYST injection for cryopyrin-associated periodic syndromes, including familial cold auto-inflammatory syndrome and muckle-wells syndrome; and ZALTRAP injection for intravenous infusion to treat metastatic colorectal cancer; and develops product candidates for treating patients with eye, allergic and inflammatory, cardiovascular and metabolic, infectious, and rare diseases; and cancer, pain, and hematologic conditions. It has collaboration and license agreements with Sanofi; Bayer; Teva Pharmaceutical Industries Ltd.; Mitsubishi Tanabe Pharma Corporation; Alnylam Pharmaceuticals, Inc.; Roche Pharmaceuticals; and Kiniksa Pharmaceuticals, Ltd., as well as has an agreement with the U.S. Department of Health and Human Services, as well as with Zai Lab Limited; Intellia Therapeutics, Inc.; Biomedical Advanced Research Development Authority; and AstraZeneca PLC. The company was incorporated in 1988 and is headquartered in Tarrytown, New York.

Fonds investis

Les fonds suivants ont investi dans : REGENERON PHARMACEUTICALS INC investi :

Fonds
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Vol. en millions
2.094,68
Part (%)
4,91 %
Fonds
iShares Edge MSCI USA Minimum Volatility ESG UCITS ETF USD (Acc)
Vol. en millions
23.196,45
Part (%)
1,33 %
Fonds
iShares Edge MSCI World Minimum Volatility UCITS ETF EUR Hedged (Acc)
Vol. en millions
1.295,63
Part (%)
1,25 %
Fonds
iShares Edge MSCI World Minimum Volatility UCITS ETF USD (Dist)
Vol. en millions
33,86
Part (%)
1,25 %
Fonds
iShares MSCI World Health Care Sector UCITS ETF USD (Dist)
Vol. en millions
3.294,59
Part (%)
0,90 %

Données de l'entreprise

Nom REGENERON PHARMACEUTICALS INC
Société Regeneron Pharmaceuticals, Inc.
Symbole REGN
Site web https://www.regeneron.com
Marché d'origine XNAS NASDAQ
WKN 881535
ISIN US75886F1075
Type de titre Action
Secteur Healthcare
Industrie Medical - Pharmaceuticals
PDG Dr. Leonard S. Schleifer M.D., Ph.D.
Capitalisation boursière 60 Mrd.
Pays États-Unis d'Amérique
Devise USD
Employés 15,1 T
Adresse 777 Old Saw Mill River Road, 10591-6707 Tarrytown
Date d'introduction en bourse 2014-11-05
Dividendes de 'REGENERON PHARMACEUTICALS INC'
Date ex-dividende Dividende par action
20.05.2025 0,88 USD
20.02.2025 0,88 USD

Symboles boursiers

Nom Symbole
Frankfurt RGO.F
London 0R2M.L
NASDAQ REGN

Autres actions

Les investisseurs qui détiennent REGENERON PHARMACEUTICALS INC ont également les actions suivantes dans leur portefeuille :
ADOBE INC
ADOBE INC Action
ALPHABET INC - CLASS A
ALPHABET INC - CLASS A Action
AMAZON.CO INC
AMAZON.CO INC Action
APPLE INC
APPLE INC Action
DocGo Inc. - Common Stock
DocGo Inc. - Common Stock Action
EMC CORP           13/23
EMC CORP 13/23 Obligation
INTEL CORP
INTEL CORP Action
META PLATFORMS INC
META PLATFORMS INC Action
MICROSOFT CORP
MICROSOFT CORP Action
NVIDIA CORP
NVIDIA CORP Action
PAYPAL INC
PAYPAL INC Action
TESLA INC
TESLA INC Action
UNIVERSAL MUSIC GROUP EO1
UNIVERSAL MUSIC GROUP EO1 Action
XTRI-M.N.G.I.I. 1CDLA
XTRI-M.N.G.I.I. 1CDLA ETF
La plateforme financière MoneyPeak suit et analyse les investissements et les portefeuilles. Du dépôt de titres à l'achat de crypto.
Utile, simple et gratuit. Actions, ETF, ETC, ETN, indices, fonds, obligations, certificats, devises, options, droits de souscription.
Mentions légales Protection des données Blog Communauté Retour d'information Changelog
Im App Store herunterladen Bei Google Play herunterladen
Tous droits réservés © LCP GmbH 2025